Yafei Yu
Washington University in St. Louis(US)Qilu Hospital of Shandong University(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Blood groups and transfusion, Chronic Lymphocytic Leukemia Research, Autoimmune Bullous Skin Diseases, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → High‐dose dexamethasone or all‐trans‐retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia(2017)86 cited
- → Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients(2024)60 cited
- → High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial(2020)59 cited
- → Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial(2021)56 cited
- → Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia(2021)32 cited
- → Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990–2019: Estimation based on Global Burden of Disease Study 2019(2021)25 cited
- → The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia(2020)20 cited
- → Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia(2021)12 cited
- → Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro(2021)10 cited
- → Single‐dose versus low‐dose rituximab in corticosteroid‐resistant or relapsed ITP: A multicenter, randomized, controlled study(2022)9 cited